Clinical Pearls Sexually Transmitted Infections March 8, 2014
|
|
- Bennett Heath
- 7 years ago
- Views:
Transcription
1 Clinical Pearls Sexually Transmitted Infections March 8, 2014 Michael F. Rein, MD, MACP, FIDSA Professor Emeritus of Medicine Harrison Distinguished Educator University of Virginia Dr. Rein has no conflicts of interest to declare.
2
3 Preliminary pearl Management of STI always involves consideration of more than one individual: source or spread cases
4 Case 1 A 23 year-old woman is entering into a new heterosexual relationship and has been asked by her intended to be evaluated for genital herpes. She has had only penile-vaginal intercourse, six prior sexual partners, and no history of genital or orolabial lesions. She presents having obtained type-specific HSV serology which is positive for HSV-1 and negative for HSV-2, asking for guidance.
5 Question 1: What can you tell her regarding possible genital herpetic infection? 1. Nothing 2. Genital herpes is very unlikely but is possible 3. She probably has orolabial herpes acquired as a baby and should be careful about felatio 4. She has genital herpes
6 Herpes Simplex Types 1 and 2 DNA viruses Differ in DNA content Share many antigens but several are unique Glycoprotein G Cross-protection is incomplete
7 HSV-2 seroprevalence: men and women (95% confidence intervals rounded off) NHANES yo 1.0% (1-2) 1.2% (1-2) yo 10.6% (8-12) 9.9% (9-11) yo 22.1% (20-24) 19.3% (17-21) yo 26.3% (24-29) 25.6% (23-28) TOTAL 17.2% (17-19) 16.7% (15-17) Little change between these two time intervals Highest incidence in ages of sexual activity Beware of cohort effects Bradley H, et al: J Infect Dis 2014;209;325-33
8 HSV-1 Genital Infection Overall prevalence: at least 35% of genital herpes In newly acquired cases among young people: about 70% Ryder: Sex Transm Infect 2009, online; Pena KC, et al: J Clin Microbiol 2009; E publication, November 17, doi: /jcm
9 Why do we expect to see more genital HSV-1? More oral sex, and this among younger people Less condom use during oral sex Fewer very young people experiencing nonvenereal acquisition and therefore first exposed sexually Less crowding Better hygiene More care regarding people with known orolabial HSV and babies (Aunt Edna)
10 HSV-1 seroprevalnce in men and women (95% confidence intervals rounded off) NHANES: yo: 39.0% (37-41) 30.1% (27-33) yo: 54.4% (52-57) 49.5% (46-52) yo: 63.5% (61-66) 61.8% (59-65) yo: 65.3% (63-68) 63.6% (60-67) TOTAL 57.9% (56-60) 53.9% (52-56) Decrease in prevalence in presexual ages Overall prevalence of antibody is high Beware of cohort effects Bradley H, et al: J Infect Dis 2014;209;325-33
11 Answer 1 is correct. A person with HSV-1 antibody may have genital herpes. Given the high prevalence of genital HSV-1, such infection cannot be ruled out. Because of the high prevalence of nonvenereal HSV-1 infection, genital herpes cannot be ruled in on serological grounds alone.
12 Clinical Pearls HSV-1 is now the most commonly acquired genital herpes, so type-specific serology is often useless. A sexual history must include questions about oral (and anal) sex The only sexually transmitted condition one cannot acquire through oral sex is pregnant
13 Case 2 A 28 year-old man attends a sales conference in Las Vegas. On his last night there, he has unprotected penile-vaginal sex with a prostitute. The following night he has penile-vaginal and oral-insertive sex with his wife. Two days later he develops urethral discharge and dysuria, and you diagnose him with gonorrhea. He asks if you can provide him with medication to give to his wife.
14 Question 2: Should you provide the patient with medication for his wife 1. No (expedited patient therapy)? 2. You cannot do it, because it is not legal in Virginia 3. You will not do it, because data have shown that it is ineffective 4. Yes, in this particular case (maybe)
15 Four questions you should ask yourself about expedited therapy Does it work? Is it legal? Is it ethical? What are the downsides?
16 Does expedited patient therapy work?
17 EPT (slightly) Reduces Reinfection Rate in STD Clinic Baltimore STD Clinic October 2007-March heterosexual patients, 50% male EPT for at least 1 partner Vs patients January 2006-June 2007 Reinfection rate: With EPT: 2.1% Without EPT 3.4% Note: historical controls 2010 National STD Prevention Conference (NSTDP): Abstract P86. Presented March 10,
18 The Effectiveness of Expedited Partner Treatment on Re-Infection Rates 20% 15% GONORRHEA P=.02 CHLAMYDIA P=.17 10% 5% 0% 11% 13% 11% 3% Usual Care EPT Usual Care EPT Golden M, et al. N Engl J Med 2005 Feb 17;352(7):
19 Is expedited patient therapy legal?
20 Expedited Rx - Politics House joint resolution No. 147 Offered: January 11, 2012 Patron: Mr. Herring Joint Commission on Health Care be directed to study options for implementing To complete its meetings by November 30, 2013 Submit findings and recommendations no later than the first day of the next regular session of the General Assembly for each year February 2, 2012: Laid on table by voice vote February 14, 2012: Left in Committee on Rules
21 Code of Virginia a practitioner may prescribe Schedule VI antibiotics and antiviral agents to other persons in close contact with a diagnosed patient Consistent with recommendations of the Centers for Disease Control and Prevention or the Department of Health bona fide practitioner-patient relationship.with the diagnosed patient in the practitioner's professional judgment, the practitioner deems there is urgency to begin treatment to prevent the transmission of a communicable disease met all requirements for the close contact except for the physical examination required such emergency treatment is necessary to prevent imminent risk of death, life-threatening illness, or serious disability. Individualize!!! Uhhhh: schedule VI antibiotics?????
22 Virginia Board of Pharmacy Guidance Document , 7/1/12 In Virginia all prescription drugs are categorized into schedules. Schedules I through V, for the most part, mirror the federal schedules. All prescription or legend drugs not included in Schedules II through V are placed in Schedule VI in Virginia and are also referred to as controlled drugs or substances within the Drug Control Act. This is sometimes confusing as the term controlled is usually applied only to drugs in Schedules II through V.
23 Is expedited patient therapy ethical?
24 Expedited therapy approved by CDC American Bar Association American Medical Association Society for Adolescent Health and Medicine American Academy of Pediatrics American College of Obstetrics and Gynecology American Congress of Obstetricians and Gynecologists
25 2012 Gonorrhea Therapy Recs Ceftriaxone 250 mg im plus: Azithromycin 1 gm po or Doxycycline 100 mg po twice daily for 7 days Even if chlamydia-negative Azithromycin preferred: Single dose so better compliance Less resistance than to doxycycline CDCP: MMWR 2012; 61:590-4
26 Gonococcal cephalosporin resistance Courtesy:KG Ghanem Combined effects of several chromosomal mutations NEJM 2012;366(6):485-7 Oral cephalosporin resistance documented in the U.S. MICs increasing to injectable cephalosporins Oral and injectable cephalosporin resistance documented in the Far East and Europe MMWR 2011 Jul 8;60(26):873-7
27 Recommended by CDCP for expedited therapy Cefixime 400 mg po plus: Azithromycin 1 gm po Note that this is not first-line therapy
28 Is expedited patient therapy ethical? CDC currently says (2012) that oral regimens should not be used to treat gonorrhea Do not give oral cefixime 400 mg po as a single dose Use ceftriaxone 250 mg im But EPT must use oral regimens Here s a less-effective regimen for your partner Does partner have a right to know why he/she is being treated? Does partner have a right to counseling, testing for other STI, and test of cure?
29 What are the downsides? Cannot ensure that partner actually got treated Split medication among multiple partners? Saved for future use? Sold on the street? Cannot evaluate partner for other STI Coprevalence Cannot provide counseling Cannot document adequate treatment Beware of β-lactam allergy
30 Correct answer: 4 EPT is legal, recommended by many, and moderately effective It may be appropriate in selected cases, e.g. when the partner absolutely cannot be evaluated
31 Clinical Pearls Providing medication (EPT) to a patient to give to a partner is permitted in Virginia. One should carefully individualize, and EPT should not be the default position. Some things that happen in Vegas do not, in fact, stay in Vegas.
32 Case 3 A 54 year old man is referred because he had a positive treponemal test (e.g. Bioplex IgG) and a negative RPR when attempting to donate blood. He has no past history of syphilis or treatment thereof. He was treated for gonorrhea while in the service 30 years previously, with resolution of his symptoms. Physical examination is normal.
33 Question 3: What is the next step 1. Repeat the Rapid Plasma Reagin in 3 months 2. Obtain a different nontreponemal test (e.g. VDRL) 3. Obtain a different treponemal test (e.g. TPPA) 4. No further workup is necessary
34 Uses of Tests for Syphilis Classical: Nontreponemal first, and if positive go on to treponemal Newer: Treponemal first, and if positive go on to nontreponemal for quantitation Followup on therapy: Nontreponemal only (must use same test throughout) RPR may yield higher titers than does VDRL Q3 months to fourfold drop (pick up 85% of successes) Annually to stable titer Ghanem KJ, et al: Sex Transm Infect 2007;83:
35 Advantages of treponemal first More sensitive than nontreponemals (VDRL, RPR) in most stages of syphilis Not entirely true in primary syphilis More specific than nontreponemals But Bayes s theorem will still hurt you in a very low prevalence population: low positive predictive value Can be automated, reducing technician time and increasing throughput Marangoni A, et al: Clin Diagn Lab Immunol 2005;12: Loeffelholz MJ, Binnicker MJ: J Clin Microbiol 2012;50:2-6
36 Disadvantages of treponemal first Confusion regarding approach to discrepant trep+/nontrep- tests Lower positive predictive value than when it follows reactive RPR (Bayes again) Currently higher cost in low-prevalence populations Use traditional approach in low-volume laboratories Stays positive after adequately treated infection Loeffelholz MJ, Binnicker MJ: J Clin Microbiol 2012;50:2-6
37 Treponemal +/ Nontreponemal - Early primary syphilis Prozone phenomenon Late syphilis Tabes Paresis Some cases of adequately treated early syphilis Lyme disease 37
38 The Prozone Phenomenon Not seen with treponemal tests Seen in ~2% of serologic tests Antibody excess in very high titers No lattice formation Especially in 2 syphilis So a cause of trep+/nontrep- Eliminated by automatically diluting out nonreactive RPRs Beware of private labs 38
39 Cross reactivity between syphilis treponemal tests and Lyme disease Lyme +/Treponemal +/ RPR- 1/10 10% (95% CI: ) 1/25 4% (95% CI: ), a new, treponemal test 6 cases: False-positive Lyme screens in syphilis (negative Lyme Western Blot) Very small numbers: This space reserved for future data (?) Maragoni: J of Clin Lab Analysis 2009; 23 : 1 6; 2011 unpublished data on Syphilis Health Check ; Naesens R, et al: Acta Clin Belg 2011;66:
40 Interpretation of the two tests Treponemal reactive + nontreponemal reactive = past or present syphilis Or: yaws, pinta, bejel Nontreponemal reactive + treponemal nonreactive = biological false positive No need to work up if an isolated finding Treponemal reactive + nontreponemal nonreactive =?????? 40
41 Treponemal +/Nontreponemal - Treat patients not lab tests Very careful history and physical examination Especially Hx of prior syphilis Hx of other STD Consult Reactor File (call Health Department) Consider different treponemal test (CDC) Evaluate sexual partners
42 UVA: Bioplex IgG ELISA 3 recombinant antigens: 15kDA 17kDA 47kDA Measured separately, then highest titer reported Warning: does not exclude syphilis within three weeks of acquisition Does not discriminate from yaws, pinta, (bejel)
43 Reverse serology at UVA 2012 Courtesy: Walter Olivera Syphilis Bioplex IgG 6473 Reactive 235 (3.6%) Equivocal 18 (0.3%) Reflex RPR 253 Reactive 85 (34%) Nonreactive 168 (66%) Previously reactive (i.e. treated) 28 TPPA 140 Reactive 78 (56%) Nonreactive 62 (44%)
44 Treponemal+/Nontreponemal- History of previous syphilis therapy: No further treatment indicated If high-risk behavior, may follow for increasing RPR titer No prior history of syphilis treatment Perform additional treponemal test (TP-PA, FTA-ABS) Preferably one based on a different antigen If positive, treat for late-latent syphilis If negative, consider yet another treponemal test CDC:MMWR 2008;57:872-5; Park IU, et al: J Infect Dis 2011;204:
45 Correct answer: 3 This is becoming a far more common scenario. Obtain a second treponemal test that uses a different antigen (e.g. TPPA vs recent ELISAs etc).
46 Clinical Pearl In the setting of an isolated finding of treponemal-reactive, nontreponemal-nonreactive, perform a different treponemal test (Virginia: usually TPPA) as the tiebreaker. If the second treponemal test is reactive, manage for syphilis of undetermined duration. If the second treponemal test is negative, syphilis is ruled out.
47 Case 4 An 18 year-old heterosexual man presents with a thin urethral discharge and mild dysuria for three days. You appropriately treat him with ceftriaxone/azithromycin. He promises that he will not have sex until he returns for reevaluation in 10 days. Surprisingly, his dual NAAT is negative for N. gonorrhoeae and C. trachomatis. When he returns, he says that he is only slightly better, and on examination, he still has a discharge.
48 Question 4: Your response Retreat with initial regimen and strongly advise abstinence and referral of sexual partners Retreat with double-dose regimen: ceftriaxone 500 mg im and azithromycin 2 gm po Retreat with metronidazole 2gm once and moxifloxacin 400 mg po qd for 10d No retreatment is indicated: this is not infectious
49 Nongonococcal Urethritis A syndrome with multiple causes Epidemiological treatment is important If you treat a patient with a particular regimen; insure that partner(s) receives the same treatment Don t rely too much on chlamydial tests Mycoplasma genitalium is a newly recognized and important pathogen 49
50 Etiologies of NGU Chlamydia trachomatis 25% Mycoplasma genitalium 10%-25% Ureaplasma urealyticum 16%-26% Trichomonas vaginalis 1%-16%(??) Enterobacteriaceae Herpes simplex Ideopathic 50
51 M. genitalium as a cause of NGU Median prevalence among men with nonchlamyidal NGU = 25% (10%-38%) Prevalence vs asymptomatic control group Statistically significant in 16/22 studies (73%) Odds ratios: Dose-response relationship to severity Clinical resolution associated with elimination of organism Manhart LE, et al: Clin Infect Dis 2011;53(S3):S
52 Mycoplasma genitalium in women Cervicitis (weaker) Endometritis (strong) Salpingitis (strong) Asymptomatic carriage Sweden: 6% US STD Clinics: 7% Britain, pregnant: 0.7% 52
53 Treatment of M genitalium urethritis Microbiological cures, pooled data Doxycycline 100 mg twice daily for 7-8 days Cured 88/212 (42%) of men Azithromycin, 1 gm Cured 371/466 (80%) of men Longer courses of azithromycin: no demonstrated advantage Manhart LE, et al: Clin Infect Dis 2011;53(S3):S129-42
54 Retreatment of M. genitalium Microbiologic failures after second treatment: Doxycycline Azithromycin 29% Azithromycin Doxycycline 70% Microbiologic failures after subsequent treatment with moxifloxacin: 12%-15% Zoler ML: Internal Medicine News 9/25/13 from Manhart LE: ISSTDR/IUASTDI
55 M. genitalium induced resistance to macrolides 15 patients infected with M. genitalium Pretreatment isolates sensitive to azithromycin Failed treatment with azithromycin Persistent infection Organisms now resistant to azithromycin Sensitive to moxifloxacin but not some older fluoroquinolones Cured with moxifloxacin 400 mg daily by mouth for 10 days Do not use ciprofloxacin! Jensen, JS et al: Clin Infect Dis 2008;47: Walker J, et al: Clin Infect Dis 2013;56:
56 Empirical approach to NGU treatment failures Tetracycline/Doxycycline failure: Metronidazole/Tinidazole for trichomoniasis Azithromycin for mycoplasmas Azithromycin failure: Metronidazole/Tinidazole for trichomoniasis Moxifloxacin 400 mg orally daily for 10 days Also covers C. trachomatis Not FDA approved CDC: 2010 STD Rx Recs; Hamasuna et al: Sex Trans Infect
57 We should treat all gonorrhea cases for coincident NGU Patients with gonorrhea may be carrying one of the other causes of NGU, like M. genitalium Use dual therapy even if negative for C. trachomatis If you don t use dual therapy: Beware of postgonococcal urethritis Patient treated for gonococcal urethritis with β-lactam Partial response or response with relapse in absence of reexposure Treat for agent of NGU Treat partners as well Dose of azithromycin 1 gm 57
58 Correct answer: 3 NGU treatment failures should be retreated with metronidazole 2gm po single dose and moxifloxacin (Avelox ) 400 mg po daily for 10 days. Be sure to treat partners as well.
59 Pearls Mycoplasma genitalium is an important cause of NGU and of genital disease in women Because of resistance, treatment-failure NGU should be retreated with (metronidazole and) moxifloxacin Gonorrhea, even if chlamydia-negative, should be treated with dual therapy
60
CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H.
CDC 2015 STD Treatment Guidelines: Update for IHS Providers Sharon Adler M.D., M.P.H. Clinical Faculty, CA Prevention Training Center Disclosure Information Sharon Adler MD, MPH I have no financial relationships
More informationExpedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon
Expedited Partner Therapy (EPT) for Sexually Transmitted Diseases Protocol for Health Care Providers in Oregon Oregon Health Authority Center for Public Health Practice HIV/STD/TB Section Principles of
More informationTHIS IS AN OFFICIAL NH DHHS HEALTH ALERT
THIS IS AN OFFICIAL NH DHHS HEALTH ALERT Distributed by the NH Health Alert Network Health.Alert@nh.gov August 13, 2015 1400 EDT (2:00 PM EDT) NH-HAN 20150813 Updated Centers for Disease Control (CDC)
More information2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential. STD Treatment Guidelines. How are the guidelines prepared?
2014 CDC Treatment Guidelines for STDs What s New, What s Important, What s Essential Bradley Stoner, MD, PhD Associate Professor, Washington University School of Medicine Medical Director, St. Louis STD/HIV
More informationFrequently Asked Questions
Guidelines for Testing and Treatment of Gonorrhea in Ontario, 2013 Frequently Asked Questions Table of Contents Background... 1 Treatment Recommendations... 2 Treatment of Contacts... 4 Administration
More informationTREATMENT OF STI CONTACTS
This decision support tool is effective as of October 2014. For more information or to provide feedback on this or any other decision support tool, email certifiedpractice@crnbc.ca TREATMENT OF STI CONTACTS
More informationCalifornia Guidelines for STD Screening and Treatment in Pregnancy
California Guidelines for STD Screening and Treatment in Pregnancy These guidelines were developed by the California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch
More informationSTANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT
STANDARD PROTOCOL STD AND HIV SCREENING AND EPIDEMIOLOGIC STD TREATMENT RELEASE DATE: REVIEW INTERVAL: YEARLY REVIEW DATE: SITE/SERVICE UNIT: IMPLEMENTATION DATE: REVIEWED BY: CONTACT: APPROVED BY: CONTENTS
More informationThe Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011
The Minnesota Chlamydia Strategy: Action Plan to Reduce and Prevent Chlamydia in Minnesota Minnesota Chlamydia Partnership, April 2011 Section 5: Screening, Treating and Reporting Chlamydia While the information
More informationFrequently Asked Questions
Frequently Asked Questions Testing for Gonorrhea Q1: What test should be completed for accurately diagnosing gonorrhea? A1: Testing is done with either a culture or a NAAT (nucleic acid amplification test).
More informationDiagnosis and Treatment Regimes for Syphilis By Dr John Bannister
Diagnosis and Treatment Regimes for Syphilis By Dr John Bannister Syphilis: Serological Testing Introduction In an ideal world a practitioner would have assessed a patient s medical history with regards
More informationChanges in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011
Changes in the 2010 STD Treatment Guidelines: What Adolescent Health Care Providers Should Know February 2011 Gale Burstein, MD, MPH, FAAP, FSAHM 1 Amanda Jacobs, MD, FAAP, 2 Dmitry Kissin, MD, MPH, 3
More informationSTI case management. Francis Ndowa - GFMER Theodora Wi - WHO
Training Course in Sexual and Reproductive Health Research 2014 Module: Principles and Practice of Sexually Transmitted Infections Prevention and Care STI case management Francis Ndowa - GFMER Theodora
More informationGLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS
GLOBAL OVERVIEW OF ANTIMICROBIAL RESISTANCE STD AGENTS IN Dr.P.Bhalla Director Professor and Head Dept. of Microbiology Maulana Azad Medical College New Delhi, INDIA STDs & RTIs l HIV l Gonococcal infections/
More informationSexually Transmitted Infections (STI) One Day Update
Sexually Transmitted Infections (STI) One Day Update February 2015 Overview STI Guideline Changes National STI Services Results Reporting High Transmission Areas: Key Populations STI Guideline Changes
More information12/3/2015. M genitalium and urethritis and cervicitis. Consider M gent Rx in persistent /recurrent urethritis and in persistent cervicitis and PID
M genitalium and urethritis and cervicitis Consider M gent Rx in persistent /recurrent urethritis and in persistent cervicitis and PID Azithromycin 1 gm more effective odoxy ineffective oaz Resistance
More informationMANAGING HERPES. Living and loving with hsv. American Social Health association. by Charles Ebel & Anna Wald, M.D., M.P.H.
MANAGING HERPES Living and loving with hsv by Charles Ebel & Anna Wald, M.D., M.P.H. American Social Health association RESEARCH TRIANGLE PARK, NORTH CAROLINA contents contents Preface xi Acknowledgments
More informationGONORRHOEA. Use of lidocaine as a diluent when using ceftriaxone (see Appendix 1)
Key practice notes: 1 st line therapy GONORRHOEA Decreasing sensitivity of gonorrhoea to cephalosporins is now a real threat: CEFTRIAXONE 500mg IM stat first-line for all gonococcal infections AZITHROMYCIN
More informationYes, I know I have genital herpes:
Counseling Messages for Herpes Simplex Type II (HSV-II) Genital herpes Always take the time to attend to the participant s feelings and emotional state; for some people, this is the most devastating news
More information2010 STD Treatment Guidelines: Update for Primary Care Providers
2010 STD Treatment Guidelines: Update for Primary Care Providers Sharon Adler, MD MPH STD Control Branch, California Department of Public Health California STD/HIV Prevention Training Center Overview CDC
More informationCalifornia Gonorrhea Treatment Guidelines
Califnia Gonrhea Treatment Guidelines These guidelines were developed by the Califnia Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch in conjunction with the Califnia
More informationHow can herpes simplex spread to an infant?
CHAPTER 3 HERPES AND PREGNANCY As an expectant parent eagerly awaiting the birth of your new baby, you are probably taking a number of steps to ensure your baby s health. One step many experts recommend
More informationRhode Island Department of Health Division of Infectious Diseases and Epidemiology
Rhode Island Department of Health Division of Infectious Diseases and Epidemiology STD (Sexually Transmitted Disease) PROGRAM Expedited Partner Therapy (EPT) for STDs Guidance for Medical Providers in
More informationAntimicrobial Resistance & Infections. Clinical Perspectives
Antimicrobial Resistance & Sexually Transmitted Infections Clinical Perspectives Outline Neisseria gonorrhoeae Global threat of untreatable gonorrhoea Mycoplasma genitalium Rapid loss of treatment options
More informationSyphilis Fast latex Agglutination Test: A Rapid Confirmatory Test for Syphilis
Syphilis Fast latex Agglutination Test: A Rapid Confirmatory Test for Syphilis Martha B. Fears and Victoria Pope* Division of AIDS, STD, and TB Laboratory Research, National Center for Infectious Diseases,
More informationDeveloped by: California Department of Public Health (CDPH) Sexually Transmitted Diseases (STD) Control Branch. In collaboration with:
Best Practices for the Prevention and Early Detection of Repeat Chlamydial and Gonococcal Infections: Effective Partner Treatment and Patient Retesting Strategies for Implementation in California Health
More informationDiseases that can be spread during sex
Diseases that can be spread during sex Did you know... over 65 million people in the United States have a chronic, incurable sexually transmitted disease (STD)? and that every year another 19 million persons
More informationEmerging Issues in Sexually Transmitted Diseases. Webinar. Managing STDs in Correctional Settings: Behind the Walls
Emerging Issues in Sexually Transmitted Diseases Webinar Managing STDs in Correctional Settings: Behind the Walls Please listen to the webinar on your computer using speakers or a headset. We will compile
More informationSlide 1: Chlamydia and Gonorrhea: What You and Your Clients Need to Know. Welcome to Chlamydia and Gonorrhea: What You and Your Clients Need to Know.
Slide 1: Chlamydia and Gonorrhea: What You and Your Clients Need to Know Welcome to Chlamydia and Gonorrhea: What You and Your Clients Need to Know. This is a presentation for healthcare providers about
More informationSYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization
WHO COLLABORATING CENTRE FOR RESEARCH IN HUMAN REPRODUCTION Hôpitaux Universitaires de Genève SYNDROMIC CASE MANAGEMENT OF RTIs Advantages, Limitations, Optimization Dr SALONEY NAZEER Department of Gynaecology
More informationTrichomonas vaginalis. Looking after your sexual health
Trichomonas vaginalis Looking after your sexual health 2 3 Trichomonas vaginalis Trichomonas vaginalis is a sexually transmitted infection (STI). It is sometimes referred to as trichomonas or trichomoniasis,
More informationTreatment of sexually transmitted and other genital infections
www.bpac.org.nz keyword: sti Treatment of sexually transmitted and other genital infections Key reviewer: Dr Murray Reid, Sexual Health Physician, Auckland Sexual Health Service General points: If one
More informationWA Endemic Regions STI/HIV Control Supplement
WA Endemic Regions STI/HIV Control Supplement MAY 2013 Contents INTRODUCTION... 2 HEALTH UNITS CONTACTS... 3 RATES OF CHLAMYDIA, GONORRHOEA AND SYPHILIS NOTIFICATIONS IN THE GOLDFIELDS, KIMBERLEY, MIDWEST
More informationEtiology and treatment of chronic bacterial prostatitis the Croatian experience
Etiology and treatment of chronic bacterial prostatitis the Croatian experience Višnja Škerk University Hospital for Infectious Diseases "Dr. Fran Mihaljevic" Zagreb Croatia Milano, Malpensa, 14 Nov 2008
More informationTitle: Antibiotic Guideline for Acute Pelvic Inflammatory Disease
Title: Antibiotic Guideline for Acute Pelvic Inflammatory Disease Version 3 Date ratified December 2007 Review date December 2009 Ratified by NUH Antimicrobial Guidelines Committee Gynaecology Directorate
More informationAlberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2012
Alberta Treatment Guidelines for Sexually Transmitted Infections (STI) in Adolescents and Adults 2012 General for STI Given the current rates of STI in Alberta, Some STI are under the Patients and contacts
More informationTreatment of Chlamydial Cervicitis During Pregnancy
Infectious Diseases in Obstetrics and Gynecology 3:189-192 (1995) (C) 1996 Wiley-Liss, Inc. Efficacy and Tolerance of Single-Dose Azithromycin for Treatment of Chlamydial Cervicitis During Pregnancy Joseph
More informationsigns suggesting chlamydia:
Chlamydia - uncomplicated genital - Management View full scenario When should I suspect and test for chlamydia? Women: o Test for chlamydia if they are sexually active with symptoms and signs suggesting
More informationThe Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin
The Journal of International Medical Research 1995; 23: 386-393 The Treatment ofnon-gonococcal Urethritis with Single Dose Oral Azithromycin T ERDOGRU\ A AGA9FIDAff, M ONELz,S BADUR z, 0 ANG 2 AND S TELALLOGLU
More informationAccent on Health Obgyn, PC HERPES Frequently Asked Questions
1. What is herpes? 2. How common is herpes? 3. Is there a cure for herpes? 4. What is oral herpes (cold sores)? 5. How is oral herpes spread? 6. What is genital herpes? 7. How is genital herpes spread?
More informationSTD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative treatment
STD Treatment Chart Nancy Harris, N.P. Women s Health Coordinator August 2003 Disease Treatment Alternative Pregnancy Chlamydia Chancroid Epdidymitis Gonorrhea: Uncomplicated (cx, urethra, and rectum):
More informationCDC 2015 STD Treatment Guidelines: What s new?
: What s new? Ellen Opie, RN/FNP, MPH Guest Faculty, CaliforniaPreventionTraining Center Staff, San FranciscoCity Clinic (DPH) Disclosure Information Ellen Opie, RN/FNP MPH I have no financial relationships
More informationAccent on Health Obgyn, PC HPV Frequently Asked Questions
1. What is HPV? 2. How do you get HPV? 3. How common is HPV? 4. What are the symptoms of HPV? 5. Can HPV be treated? 6. What is the HPV test and how is it different from a PAP test? 7. Can the HPV test
More informationZika Virus. Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases
Zika Virus Fred A. Lopez, MD, MACP Richard Vial Professor Department of Medicine Section of Infectious Diseases What is the incubation period for Zika virus infection? Unknown but likely to be several
More informationChlamydia THE FACTS. How do people get Chlamydia?
What is Chlamydia? Chlamydia is a common bacterial infection that is sexually transmitted and often causes no symptoms. If not treated, chlamydia can damage reproductive organs and make it difficult for
More informationSyphilis on the rise again in Germany results from surveillance data for 2011
Rapid communications Syphilis on the rise again in Germany results from surveillance data for 2 V Bremer (bremerv@rki.de), U Marcus, O Hamouda. Division for HIV/AIDS, STI and Blood-borne Infections, Department
More informationLeader's Resource. Note: Both men and women can have an STD without physical symptoms.
Leader's Resource Information on Sexually Transmitted Diseases (STDs) Signs and Symptoms of STDs Note: Both men and women can have an STD without physical symptoms. Any of the following can indicate to
More informationThe challenge of herpes
The challenge of herpes Herpes is a common and personally challenging disease Herpes is very common. One out of four adults has genital herpes. When people first hear that they are infected, many become
More information2014 2015 STD Treatment Guidelines What s New?
2014 2015 STD Treatment Guidelines What s New? Kees Rietmeijer Medical Director Denver STD Prevention Training Center Source: www.denverptc.org Source:NNPTC The More Things Change. Source: NNPTC The More
More informationHIV/AIDS: General Information & Testing in the Emergency Department
What Is HIV? HIV/AIDS: General Information & Testing in the Emergency Department HIV is the common name for the Human Immunodeficiency Virus. HIV is a retrovirus. This means it can enter the body s own
More information4/30/2013 HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS HPV CONTINUED
HPV VACCINE AND NORTH DAKOTA HPV IMMUNIZATION RATES HUMAN PAPILLOMAVIRUS (HPV) HUMAN PAPILLOMAVIRUS What is human papillomavirus (HPV)? HPV is the most common sexually transmitted infection. There are
More informationNew Brunswick Health Indicators
New Brunswick Health Indicators Issue 8, July 2013 A population health bulletin published by the Office of the Chief Medical Officer of Health Youth Sexual Health Sexual health is an important aspect of
More informationHPTN 073: Black MSM Open-Label PrEP Demonstration Project
HPTN 073: Black MSM Open-Label PrEP Demonstration Project Overview HIV Epidemiology in the U.S. Overview of PrEP Overview of HPTN HPTN 061 HPTN 073 ARV Drug Resistance Conclusions Questions and Answers
More informationSpecimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing
Specimen collection and transport for Chlamydia trachomatis and Neisseria gonorrhoeae testing Overview Chlamydia trachomatis (CT) and Neisseria gonorrhoeae (NG) infections are two of the most common sexually
More informationClinical Aspects of Diagnosis of Gonorrhea and Chlamydia Infection in an Acute Care Setting
BRIEF REPORT Clinical Aspects of Diagnosis of Gonorrhea and Chlamydia Infection in an Acute Care Setting Supriya D. Mehta, 1 Richard E. Rothman, 2 Gabor D. Kelen, 2 Thomas C. Quinn, 3,4 and Jonathan M.
More informationTHE UNITED REPUBLIC OF TANZANIA MINISTRY OF HEALTH AND SOCIAL WELFARE
THE UNITED REPUBLIC OF TANZANIA Treat for Lymphogranuloma venereum MINISTRY OF HEALTH AND SOCIAL WELFARE Appoint to return after Patient complains of Use Discharge from Continue to 2nd Refer to surgeon
More informationThe Basics of Drug Resistance:
CONTACT: Lisa Rossi +1-412-641-8940 +1-412- 916-3315 (mobile) rossil@upmc.edu The Basics of Drug Resistance: QUESTIONS AND ANSWERS HIV Drug Resistance and ARV-Based Prevention 1. What is drug resistance?
More informationHIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline
HIV (Human Immunodeficiency Virus) Screening and Pre-Exposure Prophylaxis Guideline Background... 2 Screening... 2 Recommendations... 2 Ordering and consent... 2 Indications for Periodic HIV Screening...
More informationPreface. TTY: (888) 232-6348 or cdcinfo@cdc.gov. Hepatitis C Counseling and Testing, contact: 800-CDC-INFO (800-232-4636)
Preface The purpose of this CDC Hepatitis C Counseling and Testing manual is to provide guidance for hepatitis C counseling and testing of individuals born during 1945 1965. The guide was used in draft
More informationCOMMUNICABLE DISEASE
Public Health Activities & Services Inventory Technical Notes COMMUNICABLE DISEASE CLINICAL SERVICES, SURVEILLANCE AND CONTROL In 2014, decision was made to adopt number of national public health activities
More informationENHANCING ADOLESCENT SEXUAL HEALTH
ENHANCING ADOLESCENT SEXUAL HEALTH SERVICES BY CREATING AN ADOLESCENT MEDICAL HOME Gale R. Burstein, MD, MPH, FAAP, FSAHM Commissioner, Erie County Department of Health, Associate Clinical Professor, SUNY
More informationChlamydia Challenge. CONTENTS 2010 CDC STD Treatment Guidelines SPRING 11. Texas Oklahoma Louisiana Arkansas New Mexico
Chlamydia Challenge SPRING 11 Region VI Infertility Prevention Advisory Committee (RIPAC) Arkansas, Louisiana, New Mexico, Oklahoma and Texas CONTENTS 2010 CDC STD Treatment Guidelines REGIONAL UPDATES:
More informationExpedited Partner Therapy for Chlamydia Trachomatis and Neisseria Gonorrhoeae: Guidance for Health Care Professionals in Indiana
Indiana State Department of Health Introduction Expedited Partner Therapy for Chlamydia Trachomatis and Neisseria Gonorrhoeae: Guidance for Health Care Professionals in Indiana Indiana State Department
More informationWilliam Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016
William Atkinson, MD, MPH Hepatitis B Vaccine Issues June 16, 2016 Advisory Committee on Immunization Practices (ACIP) The recommendations to be discussed are primarily those of the ACIP composed of 15
More informationInfection caused by the transmission of Trichomonas vaginalis (T. vaginalis) during sexual contact in which body fluids are exchanged.
This decision support tool is effective as of November 2015. For more information or to provide feedback on this or any other decision support tool, email certifiedpractice@crnbc.ca TRICHOMONIASIS DEFINITION
More informationA guide for people with genital herpes
A guide for people with genital herpes Contents Getting the facts 4 The key facts 6 What is genital herpes? 8 Genital herpes symptoms 10 Getting tested 12 The first outbreak 14 Recurrent outbreaks 16 Common
More informationGonorrhoea. Looking after your sexual health
Gonorrhoea Looking after your sexual health 2 Gonorrhoea Gonorrhoea is a bacterial sexually transmitted infection (STI). It can be painful and can cause serious health problems such as infertility in both
More informationSexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised)
Sexual Health and Sexually Transmitted Infections Prevention and Control Protocol, 2013 (Revised) Preamble The Ontario Public Health Standards (OPHS) are published by the Minister of Health and Long- Term
More informationPreventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64
Preventive Care Guideline for Asymptomatic Low Risk Adults Age 18 through 64 1. BMI - Documented in patients medical record on an annual basis. Screen for obesity and offer intensive counseling and behavioral
More informationMaking Sense of Your Pap and HPV Test Results
Making Sense of Your Pap and HPV Test Results Keep this booklet until you get your test results back from your doctor. U.S. DEPARTMENT OF HEALTH AND HUMAN SERVICES Centers for Disease Control and Prevention
More informationSexually Transmitted Infections (STIs) and the STI Clinic
Patient & Family Guide 2016 Sexually Transmitted Infections (STIs) and the STI Clinic Where to go. What to know. STIs are more common than you might think! www.nshealth.ca Sexually Transmitted Infections
More informationChlamydia trachomatis genital infection is the
CME Activity Inside and Online CHLAMYDIA TESTING AND TREATMENT Take a sexual history of all patients, including adolescents anyone who is sexually active is at risk for chlamydia infection. Screen sexually
More informationLyme (IgG and IgM) Antibody Confirmation
Pathology & Laboratory Medicine Lyme (IgG and IgM) Antibody Confirmation TEST UPDATE: New Test Notification Date: 1/9/2013 Effective Date: 1/7/2013 CONTACT INFO Call 802-847-5121 800-991-2799 email labmarketing@vtmednet.org
More informationWhat is HPV? Low-risk HPV types. High-risk HPV types
HPV and Cancer What is HPV? HPV is short for human papilloma (PAP-uh-LO-muh) virus. HPVs are a large group of related viruses. Each HPV virus in the group is given a number, which is called an HPV type.
More informationGLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET
GLOBAL CONCERNS ABOUT HPV VACCINES FACT SHEET When detected, HPV infection is easily managed and rarely proceeds to cancer Very few women with HPV develop cervical cancer HPV infections are only one of
More informationSomething for Everyone!
Common Sexually Transmitted Diseases: STD 101 for Clinicians Something for Everyone! Prepared by John F. Toney, M.D., Associate Professor of Medicine, Univ. of South Florida College of Medicine and Laura
More informationSEXUALLY TRANSMITTED INFECTIONS (STIs)
SEXUALLY TRANSMITTED INFECTIONS (STIs) The importance of a renewed commitment to STI prevention and control in achieving global sexual and reproductive health STIs: LARGE BURDEN AND SERIOUS CONSEQUENCES
More informationEpidemiology of Hepatitis C Infection. Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid
Epidemiology of Hepatitis C Infection Pablo Barreiro Service of Infectious Diseases Hospital Carlos III, Madrid Worldwide Prevalence of Hepatitis C 10% No data available WHO.
More informationHIV prevention and the wider UK population. What HIV prevention work should be directed towards the general population in the UK?
Shaping attitudes Challenging injustice Changing lives Policy briefing HIV prevention and the wider UK population September 2011 What HIV prevention work should be directed towards the general population
More informationClinical Scenarios CODING AND BILLING 101. Daryn Eikner, Family Planning Council Ann Finn, Ann Finn Consulting
Clinical Scenarios CODING AND BILLING 101 Daryn Eikner, Family Planning Council Ann Finn, Ann Finn Consulting 1 Always remember Follow coding guidelines If you didn t write it down, it didn t happen The
More informationGuidelines for Preventative Health Care in LGBT Populations
+ Guidelines for Preventative Health Care in LGBT Populations Katie Imborek, MD Department of Family Medicine Co-Director UI LGBTQ Clinic April 2 nd, 2014 + Objectives n Understand CDC screening guidelines
More informationNational Chlamydia Screening Programme September 2012 PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS
PATIENT GROUP DIRECTION FOR THE ADMINISTRATION OF AZITHROMYCIN FOR CHLAMYDIA TRACHOMATIS Below is a template that can be used to produce a local patient group direction (PGD) for the administration of
More informationPREVENTIVE HEALTHCARE GUIDELINES INTRODUCTION
PREVENTIVE HEALTHCARE GUIDELINES INTRODUCTION Health Plan of Nevada and Sierra Health and Life suggest that health plan members get certain screening tests, exams and shots to stay healthy. This document
More informationThe link between cervical cancer and HPV (human papillomavirus)
The link between cervical cancer and HPV (human papillomavirus) The link between cervical cancer and HPV Key facts: HPV is a virus (the human papillomavirus). Almost all abnormal Pap smear results are
More informationHIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016
HIV Pre-Exposure Prophylaxis (PrEP): A brief guide for providers updated January 2016 Daily emtricitabine/tenofovir (Truvada ) is safe and effective for reducing the risk of HIV acquisition in sexually
More informationAcute pelvic inflammatory disease: tests and treatment
Acute pelvic inflammatory disease: tests and treatment Information for you Information for you Published August 2010 Published in August 2010 (next review date: 2014) Acute What is pelvic inflammatory
More informationLyme Disease in 2013: Lessons Learned in Diagnosis
Lyme Disease in 2013: Lessons Learned in Diagnosis John N. Aucott, M.D. Assistant Professor, Department of Medicine Johns Hopkins University School of Medicine Lyme Disease Research Foundation Park Medical,
More informationLearning Objectives. Sexual Transmission. Partners. The Hidden Epidemic Published in: 1997. STD Medical Update
STD Medical Update Learning Objectives Patricia R Jennings DrPH, PA C Professor, University of Alabama at Birmingham Alabama / North Carolina Sexually Transmitted Disease Prevention and Training Center
More information2. Characteristics of staff Qualifications required. Additional requirements. Continued education & training requirements
Patient Group Direction The supply of Azithromycin 1g as a single dose by accredited Community Pharmacists to patients in receipt of a positive test result to Chlamydia trachomatis, and treatment of their
More informationThe public health approach to STD control
The public health approach to STD control WORLD BANK UNAIDS Technical Update UNAIDS Best Practice Collection At a Glance & There is a strong link between sexually transmitted diseases (STDs) and the sexual
More information9/28/2015. Sexually Transmitted Infections. STDs in Minnesota: Number of Cases Reported in 2013*
Sexually Transmitted Infections SANE-A TRAINING 2015 Barbara Kern-Pieh RN MS CNM SANE-A SANE-P STDs in Minnesota: Number of Cases Reported in 2013* Total of 23,133 STD cases reported to MDH in 2013: 18,724
More informationChlamydia. Looking after your sexual health
Chlamydia Looking after your sexual health 2 Chlamydia Chlamydia is one of the most common sexually transmitted infections (STIs). It is very easy to treat and cure. Up to one in 10 sexually active young
More informationEffective Integration of STI & HIV Prevention Programs
Effective Integration of STI & HIV Prevention Programs Jeanne Marrazzo, MD, MPH University of Washington, Seattle September 27, 2013 Key Points STIs are really common among those at highest risk of HIV
More informationTuberculosis: FAQs. What is the difference between latent TB infection and TB disease?
Tuberculosis: FAQs What is TB disease? Tuberculosis (TB) is a disease caused by bacteria (germs) that are spread from person to person through the air. TB usually affects the lungs, but it can also affect
More informationSOGC recommendation on ZIKA virus exposure for clinicians caring for pregnant women and those who intend to get pregnant
SOGC recommendation on ZIKA virus exposure for clinicians caring for pregnant women and those who intend to get pregnant Foreword The rapid emergence of Zika virus as a potential causative agent for fetal
More informationSyphilis. Looking after your sexual health
Syphilis Looking after your sexual health 2 Syphilis Syphilis is a sexually transmitted infection (STI). It is not as common as some sexually transmitted infections but if left untreated it can cause very
More informationCoding and Billing for HIV Services in Healthcare Facilities
P a g e 1 Coding and Billing for HIV Services in Healthcare Facilities The Hawai i State Department of Health STD/AIDS Prevention Branch is pleased to provide you information on billing and reimbursement
More informationINTRODUCTION: CPT CODES & ICD-9 CODES
INTRODUCTION: CPT CODES & ICD-9 CODES Current Procedural Terminology (CPT) is a listing of descriptive terms and identifying codes for reporting medical services and procedures performed by physicians.
More informationSCREENING FOR SEXUALLY TRANSMITTED INFECTIONS
SCREENING FOR SEXUALLY TRANSMITTED INFECTIONS Take history:- History of presenting problem Full sexual history (refer to guideline on sexual history taking) Relevant past medical history, including previous
More information